Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 36 results.
User Information
Export Records
  1. 1.   Prospective study of a novel, radiation-free, reduced-intensity bone marrow transplantation platform for primary immunodeficiency diseases
  2. Dimitrova, Dimana; Gea-Banacloche, Juan; Steinberg, Seth M; Sadler, Jennifer L; Hicks, Stephanie N; Carroll, Ellen; Wilder,Jennifer; Parta,Mark; Skeffington, Lauren; Hughes, Thomas E; Blau, Jenny E; Broadney, Miranda M; Rose, Jeremy J; Hsu, Amy P; Fletcher, Rochelle; Nunes, Natalia S; Yan, Xiao-Yi; Telford, William G; Kapoor, Veena; Cohen, Jeffrey I; Freeman, Alexandra F; Garabedian, Elizabeth; Holland, Steven M; Lisco, Andrea; Malech, Harry L; Notarangelo, Luigi D; Sereti, Irini; Shah, Nirali N; Uzel, Gulbu; Zerbe, Christa S; Fowler, Daniel H; Gress, Ronald E; Kanakry, Christopher G; Kanakry, Jennifer A
  3. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020, JAN; 26(1): 94-106.
  1. 2.   Id1 Ablation Protects Hematopoietic Stem Cells from Stress-Induced Exhaustion and Aging
  2. Singh, Satyendra K; Singh, Shweta; Gadomski, Stephen; Sun, Lei; Pfannenstein, Alexander; Magidson, Valentin; Chen, Jack; Kozlov, Serguei; Tessarollo, Lino; Klarmann, Kimberly; Keller, Jonathan
  3. Cell Stem Cell. 2018, Aug 02; 23(2): 252-265.e8.
  1. 3.   Transplantation of CCR5 Delta 32 Homozygous Umbilical Cord Blood in a Child With Acute Lymphoblastic Leukemia and Perinatally Acquired HIV Infection
  2. Rothenberger, Meghan; Wagner, John E; Haase, Ashley; Richman, Douglas; Grzywacz, Bartosz; Strain, Matthew; Lada, Steven; Estes, Jake; Fletcher, Courtney V; Podany, Anthony T; Anderson, Jodi; Schmidt, Thomas; Wietgrefe, Steve; Schacker, Timothy; Verneris, Michael R
  3. Open forum infectious diseases. 2018, May; 5(5): ofy090.
  1. 4.   Hydrodynamic Delivery of Human IL-15 cDNA Increases Murine Natural Killer Cell Recovery after Syngeneic Bone Marrow Transplantation
  2. Barao, I.; Alvarez, M.; Redelman, D.; Weiss, J. M.; Ortaldo, J. R.; Wiltrout, R. H.; Murphy, W. J.
  3. Biology of Blood and Marrow Transplantation. 2011, Dec; 17(12): 1754-1764.
  1. 5.   Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation
  2. Welniak, L. A.; Kuprash, D. V.; Tumanov, A. V.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sun, K.; Nedospasov, S. A.; Murphy, W. J.
  3. Blood. 2006, JAN 1; 107(1): 410-412.
  1. 6.   Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
  2. Sun, K.; Wilkins, D. E. C.; Anver, M. R.; Sayers, T. J.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Weiniak, L. A.; Murphy, W. J.
  3. Blood. 2005, NOV 1; 106(9): 3293-3299.
  1. 7.   Ex vivo expanded murine bone marrow cells with a multiple cytokine cocktail retain long-term hematopoietic reconstitution potentials
  2. Yang, Q. E.; Fong, S. E.; Li, K. G.; Gonda, M. A.; Tobin, G. J.
  3. Medical Science Monitor. 2005, JUN; 11(6): BR154-BR161.
  1. 8.   Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease
  2. Gendelman, M.; Hecht, T.; Logan, B.; Vodanovic-Jankovic, S.; Komorowski, R.; Drobyski, W. R.
  3. Journal of Immunology. 2004 172(5): 3328-3336.
  1. 9.   Effects of organ-specific loss of insulin-like growth factor-I production on murine hematopoiesis
  2. Welniak, L. A.; Karas, M.; Yakar, S.; Anver, M. R.; Murphy, W. F.; LeRoith, D.
  3. Biology of Blood and Marrow Transplantation. 2004 10(1): 32-39.
  1. 10.   Human immunodeficiency virus reservoir might be actively eradicated as residual malignant cells by cytotoxic chemotherapy
  2. Yang, Q.
  3. Medical Hypotheses. 2004 62(3): 358-363.
  1. 11.   Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
  2. Sun, K.; Welniak, L. A.; Panoskaltsis-Mortari, A.; O'Shaughnessy, M. J.; Liu, H. Y.; Barao, I.; Riordan, W.; Sitcheran, R.; Wysocki, C.; Serody, J. S.; Blazar, B. R.; Sayers, T. J.; Murphy, W. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(21): 8120-8125.
  1. 12.   Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides
  2. Ortaldo, J. R.; Young, H. A.; Winkler-Pickett, R. T.; Bere, E. W.; Murphy, W. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2004 172(2): 943-953.
  1. 13.   IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates
  2. Fry, T. J.; Moniuszko, M.; Creekmore, S.; Donohue, S. J.; Douek, D. C.; Giardina, S.; Hecht, T. T.; Hill, B. J.; Komschlies, K.; Tomaszewski, J.; Franchini, G.; Mackall, C. L.
  3. Blood. 2003 101(6): 2294-2299.
  1. 14.   Eradication of human immunodeficiency virus type 1-infected cells by a combination of antimetabolic cytotoxic chemotherapy and antiviral chemotherapy in vitro: A pilot study
  2. Yang, Q. E.; Li, K. G.; Mikovits, J. A.
  3. Journal of Infectious Diseases. 2002 186(5): 706-709.
  1. 15.   NK inhibitory-receptor blockade for purging of leukemia: Effects on hematopoietic reconstitution
  2. Koh, C. Y.; Raziuddin, A.; Welniak, L. A.; Blazar, B. R.; Bennett, M.; Murphy, W. J.
  3. Biology of Blood and Marrow Transplantation. 2002 8(1): 17-25.
  1. 16.   The role of growth hormone in T-cell development and reconstitution
  2. Welniak, L. A.; Sun, R.; Murphy, W. J.
  3. Journal of Leukocyte Biology. 2002 71(3): 381-387.
  1. 17.   The Feline Genome Project
  2. O'Brien, S. J.; Menotti-Raymond, M.; Murphy, W. J.; Yuhki, N.
  3. Annual Review of Genetics. 2002 36: 657-686.
  1. 18.   Interleukin-7 restores immunity in athymic T-cell-depleted hosts
  2. Fry, T. J.; Christensen, B. L.; Komschlies, K. L.; Gress, R. E.; Mackall, C. L.
  3. Blood. 2001 97(6): 1525-1533.
  1. 19.   Role of interleukin-12 in acute graft-versus-host disease
  2. Welniak, L. A.; Blazar, B. R.; Wiltrout, R. H.; Anver, M. R.; Murphy, W. J.
  3. Transplantation Proceedings. 2001 33(1-2): 1752-1753.
  1. 20.   Evidence for increased T cell turnover and decreased thymic output in HIV infection
  2. Douek, D. C.; Betts, M. R.; Hill, B. J.; Little, S. J.; Lempicki, R.; Metcalf, J. A.; Casazza, J.; Yoder, C.; Adelsberger, J. W.; Stevens, R. A.; Baseler, M. W.; Keiser, P.; Richman, D. D.; Davey, R. T.; Koup, R. A.
  3. Journal of Immunology. 2001 167(11): 6663-6668.
  1. 21.   Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury
  2. Panoskaltsis-Mortari, A.; Taylor, P. A.; Rubin, J. S.; Uren, A.; Welniak, L. A.; Murphy, W. J.; Farrel, C. T.; Lacey, D. L.; Blazar, B. R.
  3. Blood. 2000 96(13): 4350-4356.
  1. 22.   Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions
  2. Blazar, B. R.; Lees, C. J.; Martin, P. J.; Noelle, R. J.; Kwon, B.; Murphy, W.; Taylor, P. A.
  3. Journal of Immunology. 2000 165(9): 4901-4909.
  1. 23.   Longitudinal changes in CD4(+) T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patients
  2. Gea-Banacloche, J. C.; Martino, L.; Mican, J. M.; Hallahan, C. W.; Baseler, M.; Stevens, R.; Lambert, L.; Polis, M.; Lane, H. C.; Connors, M.
  3. Aids Research and Human Retroviruses. 2000 16(17): 1877-1886.
  1. 24.   Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes
  2. Murphy, W. J.
  3. Journal of Clinical Investigation. 2000 106(6): 745-747.
  1. 25.   Growth hormone as an immunomodulating therapeutic agent
  2. Murphy, W. J.; Longo, D. L.
  3. Immunology Today. 2000 21(5): 211-213.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel